Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2024-03-08
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Social Cognition Dysfunctions in Parkinson's Disease
NCT05230095
Social Self-Management of Parkinson's Disease
NCT03938974
Brain Mechanisms of Social Perception in Parkinson's Disease
NCT06884722
PA Behavior and HRQoL in Parkinson's Disease Patients Patients: Role of Social Cognitive Variables
NCT05575479
Socio-Clinical Factors Associated With Self-Management in Parkinson's Disease
NCT05211700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
This group includes adults who:
* Have been diagnosed with Parkinsons Disease by a healthcare professional
* Are at least 40 years old and
* Do not possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
No Intervention
Observational study with no intervention
Neurotypical adults
This group includes adults who:
* Are at least 40 years old
* Do not have a diagnosis of Parkinsons Disease or any form of dementia and
* Do not have a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
No Intervention
Observational study with no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
Observational study with no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are at least 40 years old
* Are at least 40 years old
Exclusion Criteria
Neurotypical group
* Have been diagnosed with Parkinson's disease by a healthcare professional
* Possess a diagnosis of autism or any other developmental disability (e.g., Down syndrome)
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gregory Wallace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gregory Wallace
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory Wallace, PhD
Role: PRINCIPAL_INVESTIGATOR
George Washington University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The George Washington University
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCR234859
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.